NICORD Trademark

Trademark Overview

On Tuesday, February 2, 2021, a trademark application was filed for NICORD with the United States Patent and Trademark Office. The USPTO has given the NICORD trademark a serial number of 90503585. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 3, 2023. This trademark is owned by Gamida Cell Inc.. The NICORD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations of stem cells derived from umbilical cord blood and expanded in culture for use in stem cell transplantation and regenerative therapy, in medical or clinical use
nicord

General Information

Serial Number90503585
Word MarkNICORD
Filing DateTuesday, February 2, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations of stem cells derived from umbilical cord blood and expanded in culture for use in stem cell transplantation and regenerative therapy, in medical or clinical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGamida Cell Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameGamida Cell Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Monday, July 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2022SOU EXTENSION 1 GRANTED
Thursday, October 27, 2022SOU EXTENSION 1 FILED
Thursday, October 27, 2022TEAS EXTENSION RECEIVED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 3, 2021NON-FINAL ACTION E-MAILED
Friday, September 3, 2021NON-FINAL ACTION WRITTEN
Tuesday, August 24, 2021ASSIGNED TO EXAMINER
Wednesday, May 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 5, 2021NEW APPLICATION ENTERED

Related Keywords

nicord stem transplantation cell regenerative culture therapy clinical medical expanded blood